As Covid-19 restrictions ease and people return to work, drug firms see an opportunity in both the over-the-counter (OTC) and prescription space for germ-killing nasal sprays. While big firms like Glenmark have come up with products like nitric oxide nasal sprays, smaller ones like Strassenburg too have launched ayurvedic nasal and mouth-spray combinations.
On Wednesday, Mumbai-headquartered Glenmark launched nitric oxide nasal spray (NONS), under the brand name FabiSpray, for treating adult Covid-19 patients. NONS is designed to kill the coronavirus in the upper airways, preventing it from incubating and spreading to the lungs.
The spray’s phase-3 trial in India demonstrated a 94 per cent reduction in viral load in 24 hours, and 99 per cent in 48 hours. NONS has